Geopolitical Tensions Disrupt Pharma Supply Chains

• •Geopolitical tensions around Iran are disrupting pharmaceutical supply chains.
• •Critical medicines like vaccines and insulin are particularly affected.
• •Companies should diversify suppliers and build buffer inventories to mitigate risks.

Rising geopolitical tensions, particularly around Iran, are causing significant disruptions to global pharmaceutical supply chains. Jeff Golfman, founder of Send 123, highlights that the Strait of Hormuz is a critical chokepoint affecting the availability of essential medicines, including vaccines, cancer therapies, and insulin. The ongoing conflict has led to reduced shipping capacity and increased costs, impacting procurement strategies across the industry. As supply shrinks, prices are expected to rise, affecting healthcare access worldwide. The situation exemplifies systemic vulnerabilities in global logistics, with the potential for cascading effects on health systems. The recent temporary truce does not alleviate the underlying issues of supply chain management and geopolitical instability. Companies are advised to diversify suppliers and build buffer inventories to mitigate risks.